You are here

P&T News

October 30

Treatment combines dapagliflozin and metformin
Ghrelin receptor agonist improves lean body mass in pivotal trial
Payers employ cost-control measures to limit use of pricey RA treatments
First vaccine to prevent serogroup B disease
Most Americans still don’t approve of the legislation

October 29

Once-daily pill works best in patients with abnormal kidney function
Treatment significantly reduces time to hemostasis versus gelatin sponge
Researchers assess effects of aspirin and statins
Up-and-coming technologies include mobile stroke ambulance and painless blood testing
Kappa opioid agonist reduces abuse potential

October 28

Returning medical workers should not be quarantined, agency says
Author sees opportunity to improve stroke prevention
Experts point to increased risk of harm and uncertain benefits
Sphingosine 1-phosphate receptor modulator achieves clinical remission
AKB-6548 associated with serious adverse effects

October 27

Ebola and Marburg shared common ancestor millions of years ago
Vaccines are on the horizon, but time is short, scientists say
Regulatory submission expected in mid-2015
Data presented at CHEST 2014 meeting
Guidelines allow treatment before organ damage occurs

October 24

100% of patients respond to treatment within 24 hours
Treating inflammation may be bad idea, authors say
If approved, product’s launch expected in second quarter, 2015

October 23

Electronic health records increase docs’ bureaucratic burden, authors say
Absence of single gene drives inflammation
Noninvasive method detects compounds produced by Aspergillus fungi
Capsules reduce exogenous insulin requirements in mid-stage trial

October 22

TB/HIV co-epidemic poses key challenge
Researchers see possibility of vaccine for heart disease
Authors recommend bundled payments for hospitals and physicians

October 21

Reference pricing aims to cut costs
Safety involves three key principles
Experts anticipate launch of first therapies for geographic atrophy

October 20

Disease ignored by public, neglected by doctors, experts say
Flexible custom mask covers hollow eye socket at lower cost
Morphine/naltrexone combo expected to reduce oral abuse when crushed

October 17

British research focused on the role of enzymes in bacteria
Progressive scarring of lungs leaves patients short of breath
Studies will prepare vaccine candidate for clinical trials
Top-line results released in NIH-funded comparison of effectiveness



From Sovaldi to Ebola: A Wide-ranging Interview with Dr. David Nash

A leading authority on population health, Dr. David Nash is optimistic about the future of disruptive innovation to improve healthcare in the U.S. The interview was conducted by P&T Editor Sonja Sherritze.



Nashville, TN
November 3 to November 4
Brussels, Belgium
November 12 to November 14

Free App

MediMedia App IconManaged Care, and P&T are available for free on multiple mobile platforms and devices. For Apple and iOS devices, visit the Apple Store and download the free digital application for Managed Care and P&T. Search for "Managed Care," "Pharmacy and Therapeutics," or "MediMedia."

Users of Android, Blackberry, Nook, and Kindle can view the mobile version on their respective devices by visiting these Web sites: Managed Care and P&T.